Search research articles
Contact Us
Filters
Showing results (451-460 of 527) with videos related to
Page
of 53
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
November 2, 2024
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis C
Chun-Ming Hong, Tung-Hung Su, Shih-Jer Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 4, 2024
Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma
Daniel Q Huang, Joseph K Hoang, Rubayet Kamal, et al.
Hepatology International
|
December 5, 2020
HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort
Yasuhito Tanaka, Eiichi Ogawa, Chung-Feng Huang, et al.
Scientific Reports
|
June 18, 2017
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
Mei-Hsuan Lee, Chung-Feng Huang, Hsueh-Chou Lai, et al.
Kidney International Reports
|
August 11, 2020
2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report
Philip Kam-Tao Li, Sunita Bavanandan, Rosmawati Mohamed, et al.
Hepatology International
|
August 30, 2019
Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium
Chung-Feng Huang, Etsuko Iio, Dae Won Jun, et al.
Hepatology (Baltimore, Md.)
|
May 15, 2023
Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase
Daniel Q Huang, Andrew Tran, Ming-Lun Yeh, et al.
Infectious Diseases and Therapy
|
April 9, 2025
Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study)
Chung-Feng Huang, Jeong Heo, Rong-Nan Chien, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 29, 2019
Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication
Eiichi Ogawa, Hidenori Toyoda, Etsuko Iio, et al.
The American Journal of Gastroenterology
|
October 22, 2019
Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B
Yao-Chun Hsu, Grace Lai-Hung Wong, Chien-Hung Chen, et al.
Page
of 53
Search research articles
Search
Showing results (451-460 of 527) with videos related to
Sort By:
Page
of 53
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
November 2, 2024
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis C
Chun-Ming Hong, Tung-Hung Su, Shih-Jer Hsu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 4, 2024
Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma
Daniel Q Huang, Joseph K Hoang, Rubayet Kamal, et al.
Hepatology International
|
December 5, 2020
HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort
Yasuhito Tanaka, Eiichi Ogawa, Chung-Feng Huang, et al.
Scientific Reports
|
June 18, 2017
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
Mei-Hsuan Lee, Chung-Feng Huang, Hsueh-Chou Lai, et al.
Kidney International Reports
|
August 11, 2020
2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report
Philip Kam-Tao Li, Sunita Bavanandan, Rosmawati Mohamed, et al.
Hepatology International
|
August 30, 2019
Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium
Chung-Feng Huang, Etsuko Iio, Dae Won Jun, et al.
Hepatology (Baltimore, Md.)
|
May 15, 2023
Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase
Daniel Q Huang, Andrew Tran, Ming-Lun Yeh, et al.
Infectious Diseases and Therapy
|
April 9, 2025
Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study)
Chung-Feng Huang, Jeong Heo, Rong-Nan Chien, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 29, 2019
Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication
Eiichi Ogawa, Hidenori Toyoda, Etsuko Iio, et al.
The American Journal of Gastroenterology
|
October 22, 2019
Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B
Yao-Chun Hsu, Grace Lai-Hung Wong, Chien-Hung Chen, et al.
Page
of 53